Seastar Medical Hldg Corp (ICU) Stock Price, Quote & News

Company Profile

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI)...

Industry: Biotechnology

Sector: Healthcare

Phone: 844 427 8100

Website: seastarmedical.com

Address:

3513 Brighton Boulevard, Suite 410, Denver, United States

BULLISH1975 Feb. 11 at 1:46 AM

$ICU SeaStar Medical (NASDAQ:ICU) director John Neuman significantly increased his stake in 2025, purchasing 40,000 shares for approximately $\$14,396$ on June 24, 2025, at an average price of $\$0.3599$. This followed earlier 2024 purchases totaling over $\$150,000$, bringing his total holdings to 80,000 shares. These moves signal confidence amidst the stock's high volatility.

0 · Reply

BULLISH1975 Feb. 11 at 1:43 AM

$ICU ‘Director John Neuman retired from The Dow Chemical Company in 2023 following 30 years of service, most recently as Vice President of Global Financial Accounting. In this position, he directed a team of approximately 350 professionals with responsibilities for financial accounting and reporting for a global network of more than 400 legal entities, including SEC filings. His tenure at Dow included finance integration and reporting responsibilities for several transactions, including the Rohm & Haas and Dow Corning acquisitions, and the Dow/DuPont merger. Prior to joining Dow’

0 · Reply

BULLISH1975 Feb. 11 at 1:43 AM

$ICU

0 · Reply

Yi_YandH Feb. 11 at 1:32 AM

$ICU 1) Dow Chemical’s Schlorff was hired as CEO to watch the shop. D O W 2)The US Army’s Chung was hired to bring this life saving medicine to market, where he can expand its purview to treat severe burn patients and all other indications caused by runaway immune system disfunction. -Now add in a New CFO; -a diverse & now, more than ever, dedicated and caring device training staff; -many of the USA’s finest hospitals are conducting the Adult trials and many of the finest Pediatric hospitals are buying and/or on the verge of buying! - The FDA’s HDE mandated SAVE Registry goes Bye, Bye in the next microsecond (relatively speaking). -50+ hospitals have the Pediatric unit in house by year’s end. IMO -FDA PMA SCD-ADULT by year’s end. IMO -Damn near, all time, MFing PPS lows.

2 · Reply

Yi_YandH Feb. 11 at 1:07 AM

$ICU For the 40th time in 2.44583945 years. Humes and Goldstein ain’t in this to make $$$$$$. They are healers!!! Worry about the product….the buckos will take care of themselves….eventually. >>>vvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvv

0 · Reply

CanadianDreamcast Feb. 11 at 1:04 AM

$ICU https://m.youtube.com/watch?v=MYu8hfsSXfw

0 · Reply

BULLISH1975 Feb. 11 at 1:04 AM

$ICU see you tomorrow bulls. i expect adult enrollment to be close to half of 339 this month and speeding up.

0 · Reply

CanadianDreamcast Feb. 11 at 1:02 AM

$ICU every time. Haha...Pioneering Research: David Deutsch, a British-Jewish physicist, is widely considered the "father of quantum computing" for his work on the quantum Turing machine.

0 · Reply

Yi_YandH Feb. 11 at 1:02 AM

$ICU I didn’t get any! I will hold out until Valentime’s, but not a day longer.

1 · Reply

CanadianDreamcast Feb. 11 at 1:00 AM

$ICU Quantum computing my ass....the only thing this powerful technology does is make it easier for the 1% to rob you.

0 · Reply

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

Jan 29, 2026, 8:25 AM EST - 12 days ago

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

Jan 7, 2026, 8:13 AM EST - 4 weeks ago

SeaStar Medical Announces 2026 Milestones

Jan 6, 2026, 8:53 AM EST - 5 weeks ago

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

Dec 23, 2025, 4:25 PM EST - 7 weeks ago

SeaStar Medical Announces 1-for-10 Reverse Split

Dec 2, 2025, 8:27 AM EST - 2 months ago

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

Nov 20, 2025, 9:52 AM EST - 2 months ago

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

Nov 17, 2025, 8:43 AM EST - 3 months ago

SeaStar Medical Announces Appointment of Michael Messinger as CFO

Nov 13, 2025, 4:05 PM EST - 3 months ago

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 5, 2025, 10:03 AM EST - 3 months ago

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

Sep 29, 2025, 8:36 AM EDT - 4 months ago

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Sep 24, 2025, 4:22 PM EDT - 4 months ago

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Sep 23, 2025, 8:23 AM EDT - 5 months ago

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

Sep 4, 2025, 6:13 PM EDT - 5 months ago

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:22 AM EDT - 5 months ago

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

Aug 13, 2025, 4:05 PM EDT - 6 months ago

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 7, 2025, 10:00 AM EDT - 6 months ago

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

Aug 6, 2025, 8:33 AM EDT - 6 months ago

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

Jul 31, 2025, 3:01 PM EDT - 6 months ago

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 22, 2025, 8:20 AM EDT - 7 months ago

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

Jul 16, 2025, 8:45 AM EDT - 7 months ago

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Jul 10, 2025, 3:29 PM EDT - 7 months ago

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 8, 2025, 8:05 AM EDT - 7 months ago

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

Jul 2, 2025, 4:25 PM EDT - 7 months ago

SeaStar Medical Announces Positive Nasdaq Listing Determination

Jun 25, 2025, 8:05 AM EDT - 8 months ago

SeaStar Medical Reports Update on Nasdaq Listing Status

Jun 24, 2025, 9:05 AM EDT - 8 months ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

Jun 20, 2025, 12:10 PM EDT - 8 months ago

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

Jun 11, 2025, 8:25 AM EDT - 8 months ago

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

May 28, 2025, 8:05 AM EDT - 9 months ago

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

May 14, 2025, 9:49 PM EDT - 9 months ago

SeaStar Medical Holding Corporation (ICU) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:05 PM EDT - 9 months ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

May 13, 2025, 8:05 AM EDT - 9 months ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

May 7, 2025, 10:00 AM EDT - 9 months ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

Apr 30, 2025, 8:05 AM EDT - 10 months ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

Apr 8, 2025, 8:05 AM EDT - 11 months ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Mar 27, 2025, 4:05 PM EDT - 11 months ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 24, 2025, 5:30 PM EDT - 11 months ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 18, 2025, 8:45 AM EDT - 11 months ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Feb 3, 2025, 4:05 PM EST - 1 year ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

Jan 22, 2025, 7:30 AM EST - 1 year ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

Jan 13, 2025, 8:30 AM EST - 1 year ago

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Jan 8, 2025, 8:30 AM EST - 1 year ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

Dec 23, 2024, 7:00 AM EST - 1 year ago

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

Dec 11, 2024, 6:30 AM EST - 1 year ago

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

Dec 4, 2024, 8:30 AM EST - 1 year ago

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024

Nov 22, 2024, 8:30 AM EST - 1 year ago

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

Nov 15, 2024, 8:30 AM EST - 1 year ago

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

Nov 13, 2024, 5:05 PM EST - 1 year ago

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

Nov 1, 2024, 8:30 AM EDT - 1 year ago

Record Monthly Enrollment Achieved in SeaStar Medical's Pivotal Adult AKI Trial

BULLISH1975 Feb. 11 at 1:46 AM

0 · Reply

BULLISH1975 Feb. 11 at 1:43 AM

0 · Reply

BULLISH1975 Feb. 11 at 1:43 AM

$ICU

0 · Reply

Yi_YandH Feb. 11 at 1:32 AM

2 · Reply

Yi_YandH Feb. 11 at 1:07 AM

0 · Reply

CanadianDreamcast Feb. 11 at 1:04 AM

$ICU https://m.youtube.com/watch?v=MYu8hfsSXfw

0 · Reply

BULLISH1975 Feb. 11 at 1:04 AM

$ICU see you tomorrow bulls. i expect adult enrollment to be close to half of 339 this month and speeding up.

0 · Reply

CanadianDreamcast Feb. 11 at 1:02 AM

$ICU every time. Haha...Pioneering Research: David Deutsch, a British-Jewish physicist, is widely considered the "father of quantum computing" for his work on the quantum Turing machine.

0 · Reply

Yi_YandH Feb. 11 at 1:02 AM

$ICU I didn’t get any! I will hold out until Valentime’s, but not a day longer.

1 · Reply

CanadianDreamcast Feb. 11 at 1:00 AM

$ICU Quantum computing my ass....the only thing this powerful technology does is make it easier for the 1% to rob you.

0 · Reply

BULLISH1975 Feb. 11 at 1:00 AM

$ICU companies need revenue but big valuation comes from potential LT revenue, revenue growth, Gross profit, EBITA and a few other things!!! we have everything accept the market has no idea that the adult trial is derisked. still no guarantee Adult approval but I love my odds…. sP will rerate in 2026 in anticipation of phase III POTENTIAL!!!! dyor

0 · Reply

CanadianDreamcast Feb. 11 at 12:58 AM

$ICU Quantum Computing is total slop.......Schlorff won't invest because he's soulless. Look at him. He's a doughnut. You could get a robot to do a better job. He sold out long ago.

0 · Reply

CanadianDreamcast Feb. 11 at 12:56 AM

$ICU (QUBT) (QCi) reported a trailing twelve-month (TTM) revenue of approximately $546,000 as of late 2025....Market Cap 2 Billion.....this Goy Slop. They pump these speculative fantasies while life saving legitimate companies get wrecked. It's irrational. I'm sure they get giddy about the next fake bubble they can get the goyim to fall for

0 · Reply

BULLISH1975 Feb. 11 at 12:55 AM

$ICU if i had been a bull and sold!!! I would also be praying I made the correct decision!!!! Imaging seeing this one do 500% in 2026. mmmmmmm

0 · Reply

BULLISH1975 Feb. 11 at 12:43 AM

$ICU kevin Chung and Newman has put in 40k to 80k- of their own hard earned cash into ICU in the last 18 months!!! These guys wanted shares in 2024/2025 like us! they also shocked at SP!!!! cry babies cry. Shorts had a good run but things change fast🙏

0 · Reply

BULLISH1975 Feb. 11 at 12:38 AM

$ICU its good that Eric snd Keving got more shares. my dkin in game- motivation. when you CEO or CMO you deserve to be rewarded. unfortunately most get rewarded before the big results,, this is not just ICU. Holding strong

0 · Reply

CanadianDreamcast Feb. 11 at 12:33 AM

$ICU anyone lending shares is a parasite. Usury is a parasitic financial system. It's a sin in Catholicism and it should be abolished...dividends are cool.

0 · Reply

CanadianDreamcast Feb. 11 at 12:30 AM

$ICU Canada and the States are both being destroyed by outside forces afraid of independent thinking white men. It's so obvious. Take my money you devils.

0 · Reply

CanadianDreamcast Feb. 11 at 12:25 AM

$ICU the market is the truest form of goy slop. It's intentionally irrational to destroy the will of people gifted with pattern recognition....it caters to sneaky cheats who use parasitic games to make money from a host.

0 · Reply

BULLISH1975 Feb. 11 at 12:14 AM

$ICU insiders got their performance shares!!! maybe they release the news now🤞🤞

1 · Reply

67StingRay Feb. 10 at 10:46 PM

$ICU Look at their stock holdings. They sale most of what they get. I just love giving money away.

1 · Reply

local42r Feb. 10 at 10:38 PM

$ICU the way it looks most investors will be in wheelchairs before they can even break even with this train wreck. Neutral 😐

0 · Reply

Market Cap	9.21M
Revenue (ttm)	140,000.00
Net Income (ttm)	-24.83M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-17,735.71%
Debt to Equity Ratio	0.00

Volume	42,200
Avg Vol	145,815
Day's Range	N/A - N/A
Shares Out	3.79M
Stochastic %K	19%
Beta	-1.00
Analysts	Strong Sell
Price Target	$11.00